RP-A501
3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| RP-A501 for cardiomyopathy, hypertrophic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| RP-A501 for hypertrophy, left ventricular | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| RP-A501 for lysosomal storage diseases | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |